<b>Factors Associated With Initiation of Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP Trial</b>

<b>Factors Associated With Initiation of Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP Trial</b>

<p dir="ltr"><b>KEY POINTS</b></p><p dir="ltr">· The influence of social determinants of health (SDOH) on sodium–glucose cotransporter 2 (SGLT2) inhibitor and glucagon-like peptide 1 (GLP-1) receptor agonist prescribing for people with type 2 diabete...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Linda-Marie U. Lavenburg (22189408) (author)
Otros Autores: Mitra Mosslemi (22189410) (author), Zhuoheng Han (22189411) (author), Melanie R. Weltman (22189414) (author), Alaa Alghwiri (22189416) (author), Gary Fischer (16803268) (author), Bruce L. Rollman (22189419) (author), Jonathan G. Yables (22189420) (author), Manisha Jhamb (22189425) (author)
Publicado: 2025
Materias:
Other health sciences not elsewhere classified
SGLT2 inhibitor
Long-acting GLP1 Derivative
Social Determinants - Health Care
Kidney Disease
Health Care
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares